Selvita Acquires PozLab to Expand its Drug Development Capabilities
Selvita has completed a strategic transaction in which it has acquired 100% of shares in PozLab.
Selvita | 08/05/2024 | By Aishwarya | 169
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy